Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beatriz Perdiguero

Showing results (21-30 of 62) with videos related to

Pageof 7
Sort By:
Journal of Molecular Biology|June 10, 2023
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral DiseasesBeatriz Perdiguero, Patricia Pérez, Laura Marcos-Villar, et al.
Vaccines|February 28, 2023
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune ResponsesLorena Usero, Lorna Leal, Carmen Elena Gómez, et al.
Journal of Structural Biology|December 20, 2011
Cryo X-ray nano-tomography of vaccinia virus infected cellsFrancisco Javier Chichón, Maria Josefa Rodríguez, Eva Pereiro, et al.
Vaccines|February 24, 2024
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic FrontiersEnrique Álvarez, Michela Falqui, Laura Sin, et al.
Frontiers in Cellular and Infection Microbiology|June 14, 2023
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responsesMichela Falqui, Beatriz Perdiguero, Rocio Coloma, et al.
Vaccines|September 28, 2021
Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same AntigenCarmen Elena Gómez, Beatriz Perdiguero, Lorena Usero, et al.
Plos One|March 3, 2012
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding proteinJuliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, et al.
Plos One|November 3, 2012
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensBeatriz Perdiguero, Carmen Elena Gómez, Jose Luis Nájera, et al.
Vaccines|November 26, 2024
B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, et al.
Plos Pathogens|June 23, 2009
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeJulie Delaloye, Thierry Roger, Quynh-Giao Steiner-Tardivel, et al.
Pageof 7

Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Journal of Molecular Biology|June 10, 2023
Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral DiseasesBeatriz Perdiguero, Patricia Pérez, Laura Marcos-Villar, et al.
Vaccines|February 28, 2023
The Combination of an mRNA Immunogen, a TLR7 Agonist and a PD1 Blocking Agent Enhances In-Vitro HIV T-Cell Immune ResponsesLorena Usero, Lorna Leal, Carmen Elena Gómez, et al.
Journal of Structural Biology|December 20, 2011
Cryo X-ray nano-tomography of vaccinia virus infected cellsFrancisco Javier Chichón, Maria Josefa Rodríguez, Eva Pereiro, et al.
Vaccines|February 24, 2024
Unveiling the Multifaceted Roles of ISG15: From Immunomodulation to Therapeutic FrontiersEnrique Álvarez, Michela Falqui, Laura Sin, et al.
Frontiers in Cellular and Infection Microbiology|June 14, 2023
An MVA-based vector expressing cell-free ISG15 increases IFN-I production and improves HIV-1-specific CD8 T cell immune responsesMichela Falqui, Beatriz Perdiguero, Rocio Coloma, et al.
Vaccines|September 28, 2021
Enhancement of the HIV-1-Specific Immune Response Induced by an mRNA Vaccine through Boosting with a Poxvirus MVA Vector Expressing the Same AntigenCarmen Elena Gómez, Beatriz Perdiguero, Lorena Usero, et al.
Plos One|March 3, 2012
Improving the MVA vaccine potential by deleting the viral gene coding for the IL-18 binding proteinJuliana Falivene, María Paula Del Médico Zajac, María Fernanda Pascutti, et al.
Plos One|November 3, 2012
Deletion of the viral anti-apoptotic gene F1L in the HIV/AIDS vaccine candidate MVA-C enhances immune responses against HIV-1 antigensBeatriz Perdiguero, Carmen Elena Gómez, Jose Luis Nájera, et al.
Vaccines|November 26, 2024
B and T Cell Bi-Cistronic Multiepitopic Vaccine Induces Broad Immunogenicity and Provides Protection Against SARS-CoV-2Beatriz Perdiguero, Enrique Álvarez, Laura Marcos-Villar, et al.
Plos Pathogens|June 23, 2009
Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasomeJulie Delaloye, Thierry Roger, Quynh-Giao Steiner-Tardivel, et al.
Pageof 7